Table 2 |
|||
|
B. mandrillaris RNase P genomic DNA in infected brain tissues detected by real-time PCR |
|||
|
DNA [pg] c) |
Amoebae equivalents d) |
CT e) |
|
|
|
|||
|
Murine brain tissue from non-infected mice |
> 500 |
neg |
≥ 39 |
|
Murine brain tissue from B.m.-infected mice a) |
n.d. |
n.d. |
30 |
|
|
|||
|
Human brain tissue from non-infected patients |
n.d. |
neg |
≥ 39 |
|
Human brain tissue spiked with 50 B.m. |
n.d. |
50 |
29 |
|
Human brain tissue from BAE-patient 1 b) (1:100) |
n.d. |
n.d. |
30 |
|
Human brain tissue from BAE-patient 2 b) (1:10) |
n.d. |
n.d. |
35 |
|
|
|||
|
a) A highly symptomatic CD4+ T cell-deficient mouse 14 days post intranasal infection with B. mandrillaris amoebae. b) DNA extracted from 2 fresh BAE-patient brain biopsy samples ([23] Table 1: cases 4 and 5). c) Minimal amounts of total DNA giving positive results (CT < 39). d) Minimal numbers of amoebae (calculated as amoeba DNA equivalents per PCR tube) giving positive results; neg = CT ≥ 39 for at least 500 ng total DNA. e) Range of CT values measured; neg = CT ≥ 39 or no DNA detected; n.d. = not done. |
|||
|
Kiderlen et al. BMC Microbiology 2008 8:210 doi:10.1186/1471-2180-8-210 |
|||